DE3874320T2 - Tablette zur behandlung bei progesteronmangel. - Google Patents

Tablette zur behandlung bei progesteronmangel.

Info

Publication number
DE3874320T2
DE3874320T2 DE8989900392T DE3874320T DE3874320T2 DE 3874320 T2 DE3874320 T2 DE 3874320T2 DE 8989900392 T DE8989900392 T DE 8989900392T DE 3874320 T DE3874320 T DE 3874320T DE 3874320 T2 DE3874320 T2 DE 3874320T2
Authority
DE
Germany
Prior art keywords
progesterone
wax
tablet
safflower oil
level increases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989900392T
Other languages
English (en)
Other versions
DE3874320D1 (de
Inventor
Guy E Abraham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ABRAHAM, GUY E., ROLLING HILLS, CALIF., US
Original Assignee
PHARMAGYN Inc CHAMBLEE GA US
PHARMAGYN Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAGYN Inc CHAMBLEE GA US, PHARMAGYN Inc filed Critical PHARMAGYN Inc CHAMBLEE GA US
Publication of DE3874320D1 publication Critical patent/DE3874320D1/de
Application granted granted Critical
Publication of DE3874320T2 publication Critical patent/DE3874320T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE8989900392T 1987-10-05 1988-10-03 Tablette zur behandlung bei progesteronmangel. Expired - Lifetime DE3874320T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10480887A 1987-10-05 1987-10-05
US23061688A 1988-08-10 1988-08-10
PCT/US1988/003406 WO1989002742A1 (en) 1987-10-05 1988-10-03 Tablet for use in the treatment of progesterone deficiency

Publications (2)

Publication Number Publication Date
DE3874320D1 DE3874320D1 (de) 1992-10-08
DE3874320T2 true DE3874320T2 (de) 1992-12-17

Family

ID=26801969

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989900392T Expired - Lifetime DE3874320T2 (de) 1987-10-05 1988-10-03 Tablette zur behandlung bei progesteronmangel.

Country Status (6)

Country Link
EP (1) EP0335970B1 (de)
AT (1) ATE80037T1 (de)
AU (1) AU2807089A (de)
CA (1) CA1315681C (de)
DE (1) DE3874320T2 (de)
WO (1) WO1989002742A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
GB9921933D0 (en) 1999-09-17 1999-11-17 Univ Gent Solid shaped articles comprising biologically active substances and a method for their production
FR2821555B1 (fr) 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
AU2003208679A1 (en) 2002-02-08 2003-09-02 Advanced Animal Technology Limited Control of a biological function
US20060263429A1 (en) 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
FR2947178B1 (fr) * 2009-06-29 2012-07-06 Effik Composition pharmaceutique a base de progesterone micronisee et ses utilisations
ES2895054T3 (es) 2016-08-18 2022-02-17 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Fórmula de comprimido antiparkinson con perfil de disolución mejorado

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2880135A (en) * 1952-10-30 1959-03-31 Upjohn Co 11-keto-progesterone compositions and methods of treating ketosis therewith
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3193457A (en) * 1961-06-07 1965-07-06 Syntex Corp Oral administration of 6, 16alpha-dimethyl-progesterones
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3535419A (en) * 1965-12-15 1970-10-20 Syntex Corp Veterinary compositions and methods
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
AT385654B (de) * 1984-09-04 1988-05-10 Arcana Chem Pharm Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung

Also Published As

Publication number Publication date
CA1315681C (en) 1993-04-06
EP0335970A4 (de) 1990-03-28
EP0335970B1 (de) 1992-09-02
AU2807089A (en) 1989-04-18
ATE80037T1 (de) 1992-09-15
WO1989002742A1 (en) 1989-04-06
EP0335970A1 (de) 1989-10-11
DE3874320D1 (de) 1992-10-08

Similar Documents

Publication Publication Date Title
ATE209864T1 (de) Zusammensetzung zur behandlung von patienten mit lebererkrankungen
DE3470662D1 (en) Aqueous or anhydrous cosmetic composition containing a fatty phase based on karite oil
NO963781L (no) Egenskapene i katters ansiktsferomoner
ES2175023T3 (es) Composiciones nutricionales en varias formas.
AU597822B2 (en) Transparent antiperspirant stick compositions
AU631683B2 (en) Bread improver compositions
GB8319073D0 (en) Fatty acid compositions
ES474047A1 (es) Procedimiento para preparar un cebo para moscas sinantropas
DE3874320T2 (de) Tablette zur behandlung bei progesteronmangel.
DE69126776T2 (de) Parasitizide zusammensetzung und verfahren zu ihrer herstellung und ihre verwendung
ATE272321T1 (de) Modifizierte fettmischungen
ATE33333T1 (de) Diaetetikum.
ATE43332T1 (de) Glaszusammensetzungen zur verbindung mit legierungen.
SE8800990L (sv) Hudregenererande kosmetisk komposition samt foerfarande foer framstaellning av densamma
BR8802864A (pt) Processo para a preparacao de uma composicao aquosa que consiste em clofentezina em particulas
DE69221269D1 (de) Formbares Dentalmaterial
FI944162A (fi) Maustamattomia ratamojuomaseoskoostumuksia
SE8903872D0 (sv) Food spreads
ES2038545A2 (es) Procedimiento para la fabricacion y aplicacion de piedra sintetica.
Hyun et al. A study on shear bond strength of interface between bone and titanium plasma sprayed IMZ implant in rabbits
GB2208517A (en) Middle distillate compositions with reduced wax crystal size
ES2115949T3 (es) Dihidrotestosterona para androgenoterapia.
JPS5210428A (en) A mixed perfume
BG48622A1 (en) Plastificated polyvinylchloride composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ABRAHAM, GUY E., ROLLING HILLS, CALIF., US

8328 Change in the person/name/address of the agent

Free format text: MEYER, L., DIPL.-ING., PAT.-ANW., 20354 HAMBURG

8339 Ceased/non-payment of the annual fee